Insights

Strong Market Position Sanovel's leadership in the Turkish pharmaceutical industry, with a diverse product portfolio of over 180 products and more than 60 brands, highlights opportunities to introduce complementary health solutions and expand into new treatment categories.

Global Certification & Recognition As the only Turkish pharmaceutical company approved by the US FDA, Sanovel demonstrates high quality standards, making it a reliable partner for international supply chain collaborations and advanced manufacturing services.

Innovative R&D Focus With a robust R&D center and a strong patent portfolio, Sanovel is positioned to explore partnerships in research, custom formulations, and new drug development initiatives, opening avenues for innovation-driven sales.

Strategic Partnerships Recent collaborations, such as with PharmaMar for the anticancer drug Yondelis, suggest an openness to licensing, joint ventures, and distribution agreements, presenting opportunities for strategic alliances in high-value therapeutic areas.

Technology & Infrastructure Utilizing advanced technology stacks including cloud solutions and data visualization tools, Sanovel is well-positioned for digital integration and automation solutions, creating prospects for technologies that enhance manufacturing efficiency and regulatory compliance.

Similar companies to Sanovel İlaç

Sanovel İlaç Tech Stack

Sanovel İlaç uses 8 technology products and services including Grafana, Ve Global, Google Cloud, and more. Explore Sanovel İlaç's tech stack below.

  • Grafana
    Analytics
  • Ve Global
    Analytics
  • Google Cloud
    Infrastructure As A Service
  • Google Maps
    Maps
  • C#
    Programming Languages
  • .NET
    Programming Languages
  • VMware ESXi
    Virtualisation Software
  • Microsoft IIS
    Web Servers

Sanovel İlaç's Email Address Formats

Sanovel İlaç uses at least 1 format(s):
Sanovel İlaç Email FormatsExamplePercentage
FirstLast@sanovel.com.trJohnDoe@sanovel.com.tr
94%
FirLast@sanovel.com.trJohDoe@sanovel.com.tr
3%
FirstLas@sanovel.com.trJohnDoe@sanovel.com.tr
2%
First.Last@sanovel.com.trJohn.Doe@sanovel.com.tr
1%

Frequently Asked Questions

What is Sanovel İlaç's phone number?

Minus sign iconPlus sign icon
You can contact Sanovel İlaç's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sanovel İlaç's official website and social media links?

Minus sign iconPlus sign icon
Sanovel İlaç's official website is sanovel.com.tr and has social profiles on LinkedIn.

What is Sanovel İlaç's SIC code NAICS code?

Minus sign iconPlus sign icon
Sanovel İlaç's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sanovel İlaç have currently?

Minus sign iconPlus sign icon
As of December 2025, Sanovel İlaç has approximately 1.8K employees across 3 continents, including AsiaEuropeNorth America. Key team members include Chief Operating Officer: E. K.Chief Financial Officer: M. C.Head Of Representative Office In Georgia: E. M.. Explore Sanovel İlaç's employee directory with LeadIQ.

What industry does Sanovel İlaç belong to?

Minus sign iconPlus sign icon
Sanovel İlaç operates in the Pharmaceutical Manufacturing industry.

What technology does Sanovel İlaç use?

Minus sign iconPlus sign icon
Sanovel İlaç's tech stack includes GrafanaVe GlobalGoogle CloudGoogle MapsC#.NETVMware ESXiMicrosoft IIS.

What is Sanovel İlaç's email format?

Minus sign iconPlus sign icon
Sanovel İlaç's email format typically follows the pattern of FirstLast@sanovel.com.tr. Find more Sanovel İlaç email formats with LeadIQ.

When was Sanovel İlaç founded?

Minus sign iconPlus sign icon
Sanovel İlaç was founded in 1983.

Sanovel İlaç

Pharmaceutical ManufacturingIstanbul, Turkey1001-5000 Employees

Founded in 1983 by Pharmacist Erol Toksöz, Sanovel stands as one of the leading pharmaceutical companies in Türkiye. Boasting an annual production capacity of 227 million units and EU GMP (Good Manufacturing Practices) certification, the company aspires to be a global pharmaceutical company. This vision is driven by robust R&D, an extensive product portfolio featuring over 60 brands and 180 products, and a dedicated team of over 1,600 individuals committed to fostering long and healthy lives.

Distinguished as the first and only Turkish pharmaceutical company to be approved by the American Food and Drug Administration (FDA), acknowledged as the world's foremost health authority, Sanovel obtained approval without encountering any major or critical observations. With exceptional capabilities in terms of R&D, patents and intellectual property rights, Sanovel is the pioneering company to offer equivalent products to the market in a wide range of treatment areas.

Sanovel R&D Center & Production Campus in İstanbul Silivri, started production in 2006. The production site comprises the main production unit, cephalosporin production unit, refining unit, elevated storage and social recreational facility. The production capacity is 227 million units per year.

Enjoying a leadership position in intellectual property competence within the industry, Sanovel has consistently maintained its status as the patent champion of the Turkish pharmaceutical industry, a title attributable to the company's exceptional work in the realm of intellectual property.
Guided by a strong vision, Sanovel centers its entire operation around sustainability, aiming for a balanced and valuable life for its hundreds of highly competent and passionate employees.

Sanovel is dedicated to contributing to the Turkish pharmaceutical industry and the national economy, a commitment it has upheld for four decades, with the overarching goal of promoting a lifelong health worldwide.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1983
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    Sanovel İlaç's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Sanovel İlaç's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.